Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Osel DevicesNSE:OSELDEVICE -2.37%47 Return-on-Tangible-Asset is 8.28% as of Mar. 2026, which is 24% below its 10-year median of 10.96. GuruFocus rates NSE:OSELDEVICE with a GF Score™ of 47/100. The stock has 6 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Osel Devices ranks better than 82.3% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Osel Devices's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹281 Mil. Osel Devices's average total tangible assets for the quarter that ended in Mar. 2026 was ₹3,388 Mil. Therefore, Osel Devices's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 8.28%.
The historical rank and industry rank for Osel Devices's Return-on-Tangible-Asset or its related term are showing as below:
NSE:OSELDEVICE'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 6.03 Med: 10.96 Max: 17.18
Current: 10.01
During the past 6 years, Osel Devices's highest Return-on-Tangible-Asset was 17.18%. The lowest was 6.03%. And the median was 10.96%.
NSE:OSELDEVICE's Return-on-Tangible-Asset is ranked better than 82.3% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 0.76
vs NSE:OSELDEVICE: 10.01
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Osel Devices Return-on-Tangible-Asset Related Terms
Osel Devices Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Osel Devices's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:OSELDEVICE vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Osel Devices's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Osel Devices Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Osel Devices's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Osel Devices's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 8.28% mean?
Osel Devices (NSE:OSELDEVICE) has a Return-on-Tangible-Asset of 8.28% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Osel Devices and its competitors. This is 24% below median its historical median of 10.96. Over the past decade, Osel Devices' Return-on-Tangible-Asset has ranged from 6.03 to 17.18. According to the industry distribution chart, Osel Devices ranks #151 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 17.7%.
Is Osel Devices' Return-on-Tangible-Asset too high?
Osel Devices' current Return-on-Tangible-Asset of 8.28% is 24% below median its 10-year median of 10.96. Over the past 10 years, this metric has ranged from a low of 6.03 to a high of 17.18. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.76. Osel Devices' value of 8.28% is 989.5% above this industry median. Based on the distribution chart, Osel Devices ranks #151 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Osel Devices has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Osel Devices' Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Osel Devices ranks #151 out of 853 companies for Return-on-Tangible-Asset. This places Osel Devices in the top 18% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.76. Osel Devices' value of 8.28% is 989.5% above this benchmark. Historically, Osel Devices' own Return-on-Tangible-Asset has ranged from 6.03 to 17.18 over the past decade. While the company's 10-year median is 10.96 vs. the industry median of 0.76, Osel Devices has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.76, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Osel Devices's current Return-on-Tangible-Asset of 8.28% is 989.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Osel Devices and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Osel Devices's current Return-on-Tangible-Asset is 8.28%, which is 24% below median its own 10-year median of 10.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Osel Devices stock overvalued right now?
Osel Devices (NSE:OSELDEVICE) has a current Return-on-Tangible-Asset of 8.28%. The current Return-on-Tangible-Asset is 8.28%, which is 24% below median its 10-year median of 10.96 and 989.5% above the Medical Devices & Instruments industry median of 0.76. Osel Devices' overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Osel Devices (NSE:OSELDEVICE), the current Return-on-Tangible-Asset is 8.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Osel Devices Ltd is engaged in the manufacture, trade, retail, wholesale, import, export, warehousing, storage, distribution, assembly, repair, maintenance, integration, operation, testing, installation, and resale of hearing aids and LED display components, parts, and accessories. The company also carries out research and development activities related to all kinds of hearing aids, components, parts, and accessories. it offers variuos products including advanced hearing aids designed to improve auditory experience and LED solutions tailored to various industries, while also distributing Mobile products across India. it generates majority of revenue from hearing aids.
47GF Score
Get the complete analysis for NSE:OSELDEVICE
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:OSELDEVICE has been successfully added to your 
